HUP1300496A2 - Stable pharmaceutical composition - Google Patents
Stable pharmaceutical compositionInfo
- Publication number
- HUP1300496A2 HUP1300496A2 HU1300496A HUP1300496A HUP1300496A2 HU P1300496 A2 HUP1300496 A2 HU P1300496A2 HU 1300496 A HU1300496 A HU 1300496A HU P1300496 A HUP1300496 A HU P1300496A HU P1300496 A2 HUP1300496 A2 HU P1300496A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- stable pharmaceutical
- stable
- composition
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1300496A HUP1300496A2 (en) | 2013-08-16 | 2013-08-16 | Stable pharmaceutical composition |
PCT/HU2014/000072 WO2015022560A1 (en) | 2013-08-16 | 2014-08-15 | Stable pharmaceutical composition containing bisoprolol and ramipril |
EA201690395A EA033291B1 (en) | 2013-08-16 | 2014-08-15 | Dosage unit comprising ramipril and bisoprolol hemifumarate, process for the preparation thereof and method of treating hypertension |
PCT/HU2014/000071 WO2015022559A1 (en) | 2013-08-16 | 2014-08-15 | Pharmaceutical composition containing rosuvastatin and ramipril |
HU1600414A HU231052B1 (en) | 2013-08-16 | 2014-08-15 | Stable pharmaceutical composition containing bisoprolol and ramipril |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1300496A HUP1300496A2 (en) | 2013-08-16 | 2013-08-16 | Stable pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP1300496A2 true HUP1300496A2 (en) | 2015-03-02 |
Family
ID=89991232
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1300496A HUP1300496A2 (en) | 2013-08-16 | 2013-08-16 | Stable pharmaceutical composition |
HU1600414A HU231052B1 (en) | 2013-08-16 | 2014-08-15 | Stable pharmaceutical composition containing bisoprolol and ramipril |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1600414A HU231052B1 (en) | 2013-08-16 | 2014-08-15 | Stable pharmaceutical composition containing bisoprolol and ramipril |
Country Status (3)
Country | Link |
---|---|
EA (1) | EA033291B1 (en) |
HU (2) | HUP1300496A2 (en) |
WO (2) | WO2015022559A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3501502A1 (en) * | 2017-12-20 | 2019-06-26 | Midas Pharma GmbH | Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin |
WO2021160700A1 (en) | 2020-02-10 | 2021-08-19 | Adamed Pharma S.A. | Composition comprising ramipril and indapamide |
CN115068434B (en) * | 2022-08-03 | 2023-05-09 | 昆山龙灯瑞迪制药有限公司 | Preparation method of ramipril tablet |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0050800B2 (en) | 1980-10-23 | 1995-06-07 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
DE3226768A1 (en) | 1981-11-05 | 1983-05-26 | Hoechst Ag, 6230 Frankfurt | DERIVATIVES OF CIS, ENDO-2-AZABICYCLO- (3.3.0) -OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THE MEANS CONTAINING THEM AND THE USE THEREOF |
DE3739690A1 (en) | 1987-11-24 | 1989-06-08 | Hoechst Ag | STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS |
US20030215526A1 (en) | 2002-03-08 | 2003-11-20 | Scott Stofik | Stable formulations of angiotensin converting enzyme (ACE) inhibitors |
CA2483099A1 (en) * | 2002-05-03 | 2003-11-13 | Hexal Ag | Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor |
PL1635792T3 (en) | 2003-06-26 | 2009-08-31 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical compositions of 2-aza-bicyclo¬3.3.0 -octane-3-carboxylic acid derivatives |
US20060188568A1 (en) | 2003-10-30 | 2006-08-24 | Lupin Limited | Stable formulations of ace inhibitors and methods for preparation thereof |
GB2394660A (en) | 2003-12-17 | 2004-05-05 | Niche Generics Ltd | Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide |
US20080234353A1 (en) | 2004-03-24 | 2008-09-25 | Reynir Eyjolfsson | Formulations of Ramipril |
EP1817007A2 (en) | 2004-11-05 | 2007-08-15 | King Pharmaceuticals Research and Development Inc. | Stabilized individually coated ramipril particles, compositions and methods |
CA2628955A1 (en) * | 2005-11-07 | 2007-05-18 | Edward S. Wilson | Compositions of stabilized ramipril in combination with another active agent |
CN100374462C (en) | 2005-11-21 | 2008-03-12 | 大连帝恩生物工程有限公司 | Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use |
US20070232680A1 (en) | 2006-04-04 | 2007-10-04 | Vijayabhaskar Bolugoddu | Preparation of ramipril and stable pharmaceutical compositions |
MX2008013374A (en) | 2006-04-19 | 2008-11-12 | Teva Pharma | Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane -3-carboxylic acid derivatives. |
WO2008000040A1 (en) | 2006-06-30 | 2008-01-03 | Alphapharm Pty Ltd | A stabilised composition comprising ace inhibitors |
WO2008021875A2 (en) | 2006-08-08 | 2008-02-21 | Accu-Break Technologies, Inc. | Pharmaceutical tablets containing a plurality of active segments |
WO2008065485A2 (en) | 2006-10-19 | 2008-06-05 | Torrent Pharmaceuticals Limited | Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor |
US9095519B2 (en) | 2007-02-09 | 2015-08-04 | Alphapharm Pty Ltd | Dosage form containing two or more active pharmaceutical ingredients in different physical forms |
WO2008132756A1 (en) | 2007-05-01 | 2008-11-06 | Lupin Limited | Stable pharmaceutical compositions of ramipril |
HU230877B1 (en) | 2008-09-30 | 2018-11-29 | EGIS Gyógyszergyár NyR | Stable pharmaceutical combination |
EP2272874A1 (en) | 2009-07-10 | 2011-01-12 | CSL Behring GmbH | Role of PLD1 in thrombus formation and integrin alpha IIb beta 3 activation |
CN101612403A (en) | 2009-08-13 | 2009-12-30 | 王丽燕 | The pharmaceutical composition that contains calcium antagonist, ACE inhibitor and statins |
UA113977C2 (en) | 2012-02-17 | 2017-04-10 | PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY |
-
2013
- 2013-08-16 HU HU1300496A patent/HUP1300496A2/en not_active Application Discontinuation
-
2014
- 2014-08-15 WO PCT/HU2014/000071 patent/WO2015022559A1/en active Application Filing
- 2014-08-15 EA EA201690395A patent/EA033291B1/en not_active IP Right Cessation
- 2014-08-15 HU HU1600414A patent/HU231052B1/en unknown
- 2014-08-15 WO PCT/HU2014/000072 patent/WO2015022560A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015022560A8 (en) | 2015-05-14 |
HU231052B1 (en) | 2020-02-28 |
HUP1600414A2 (en) | 2016-09-28 |
WO2015022559A1 (en) | 2015-02-19 |
EA201690395A1 (en) | 2016-07-29 |
WO2015022560A1 (en) | 2015-02-19 |
EA033291B1 (en) | 2019-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288961A (en) | Pharmaceutical compositions | |
HUE046964T2 (en) | Combined pharmaceutical composition | |
PL2943181T3 (en) | Pharmaceutical compositions | |
PL3043778T3 (en) | Pharmaceutical compositions containing refametinib | |
HK1215191A1 (en) | Low dose pharmaceutical composition | |
HK1213182A1 (en) | Pharmaceutical composition for external application | |
ZA201408333B (en) | Pharmaceutical compositions | |
EP2990038A4 (en) | Solid pharmaceutical composition | |
SG11201601477VA (en) | Pharmaceutical composition | |
SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
GB201320932D0 (en) | Topical pharmaceutical composition | |
IL242704B (en) | Pharmaceutical preparation | |
HUP1300496A2 (en) | Stable pharmaceutical composition | |
HRP20171888T1 (en) | Pharmaceutical compositions | |
HK1220143A1 (en) | Pharmaceutical composition | |
GB201304699D0 (en) | Pharmaceutical compositions | |
EP2992890A4 (en) | Pharmaceutical composition | |
IL244316A0 (en) | Novel drug formulation | |
GB201321497D0 (en) | Pharmaceutical compositions | |
GB201304625D0 (en) | New pharmaceutical composition | |
GB201312851D0 (en) | Pharmaceutical compositions | |
AU2013903813A0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC4A | Lapse of provisional application due to refusal |